SF Healthcare Week: Vera Therapeutics’ announced this week that the FDA accepted the company’s filing for atacicept, a potential new treatment for IgA Nephropathy
BiotechTV - News
00:00
FDA Interaction and Regulatory Status
Marshall summarizes breakthrough designation, clear FDA communication, and BLA acceptance with a July PDUFA date.
Play episode from 09:00
Transcript
